The article describes the AVO treatment, a combination therapy for Chronic Lymphocytic Leukemia (CLL), particularly for high-risk patients. CLL is a slow-growing cancer where abnormal white blood cells accumulate. "High-risk" CLL refers to cases with specific genetic changes (e.g., in TP53) that make the disease harder to treat.

GRACE is pleased to announce the acceptance of four rising stars into the 7th year of the GRACE Patient Education Ambassadors Program for the 2025-26 Program Year! All four candidates have shown a genuine passion for patient education and innovation in connecting with the patient community. The program will encompass the participants creating content which will be featured on the GRACE website, working alongside GRACE faculty, Board, and staff, and learning the most current and effective...

The 2025 Targeted Therapies in Lung Cancer Patient Forum was a live, virtual, interactive patient education event presented in March 2025 and led by Dr. Lyudmila Bazhenova. It included presentations and panel discussions from 11 top medical professionals covering educational topics related to molecular targets in lung cancer as well as an opportunity to ask questions of the experts in multiple Q&A sessions. The speakers presented patient-focused discussions to educate the patient and caregiver...

Da click aquí para más información y para registrarte ahora Este 9 de agosto, no te puedes perder nuestro Foro anual de pacientes de terapias dirigidas de cáncer pulmón de GRACE en ESPAÑOL. Es un evento educativo para pacientes en vivo, virtual e interactivo, que incluye presentaciones y mesas redondas que cubren una diversa gama de cánceres de pulmón y opciones de tratamiento. Este evento educativo para pacientes, en directo, virtual e interactivo, incluye presentaciones y mesas redondas que...

The panel discusses the current standard of care for patients with head and neck cancer who need surgery, the findings of the Keynote 689 study, which showed improved EFS in patients with head and neck cancers treated with pembrolizumab, the RTOG 0920 study, and how it may affect their use of cetuximab in clinic, and how surgeons view the various treatment agents for head and neck cancer, and whether they prefer certain ones. To watch the complete playlist click here:

Las biopsias líquidas están revolucionando la forma en que combatimos el cáncer, ofreciendo un futuro donde la detección y el tratamiento son más rápidos, precisos y menos invasivos.

Como parte de la Videoteca de Cáncer de Pulmón en Español 2025, oncólogos expertos discuten las opciones de tratamiento y la información más emergente en cáncer de pulmón. El Dr. Raez aborda la terapia para cánceres de pulmón EGFR y ALK, además de analizar otros tres temas de actualidad. La Dra. Viola y la Dra. Riaño también contribuyen a esta videoteca, cada una presentando tres temas relevantes sobre el cáncer de pulmón. To watch the complete playlist, click here.

The journey to conquer lung cancer is paved with scientific discovery, and the identification of the EGFR and ALK genes as crucial players marks a significant milestone. Unraveling how mutations in these seemingly small segments of our DNA can unleash the destructive force of cancer has opened up exciting new therapeutic avenues. This exploration delves into the cutting-edge world of EGFR and ALK-targeted therapies, highlighting the progress made and the ongoing quest for even more effective and personalized strategies to combat this formidable disease.

In these videos, Dr. Jared Weiss gives a brief overview of NUT Carcinoma, discusses treatment options and possible future treatment. To watch the complete playlist, click here.